US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson’s Disease Gene therapies and LRRK2 inhibition are at the forefront of prescribers’ interest, highlighting the need for a truly disease modifying therapy. Exton, Pennsylvania, Nov. 07, 2023 (GLOBE NEWSWIRE) — Parkinson’s disease (PD) is the second-most prevalent neurodegenerative disorder following Alzheimer’s disease, affecting an estimated one…

The Shyft Group to Participate in the Baird 2023 Global Industrial Conference Introduction NOVI, Mich., Nov. 07, 2023 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF), known as the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service specialty vehicle markets, has made an exciting announcement today….

LHV founder Rain Lõhmus’ gains and loses $474m from Ethereum wallet The Rise and Fall of Rain Lõhmus’ Ethereum Investment In a shocking turn of events, LHV founder Rain Lõhmus has both gained and lost a whopping $474 million from his Ethereum wallet. The account, which was originally filled with ETH purchased during Ethereum’s Initial…

Welcome to the Witty World of Share Buybacks! IG Group Holdings plc Strikes Again It’s official, folks! IG Group Holdings plc has decided to kick it up a notch and dive headfirst into the second phase of its share buyback program. For those of you not in the know, a share buyback is when a…

Investor Alert: Abbott Cooper PLLC Investigates Conn’s, Inc. STAMFORD, Conn., Nov. 07, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is currently conducting an investigation into Conn’s, Inc. (Nasdaq: CONN) on behalf of the Company’s investors. The primary focus of the investigation is to determine whether Conn’s board of directors has breached its fiduciary duty by…